Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 11;14(5):e243136.
doi: 10.1136/bcr-2021-243136.

Anti-Ma paraneoplastic opsoclonus-myoclonus syndrome

Affiliations
Case Reports

Anti-Ma paraneoplastic opsoclonus-myoclonus syndrome

Philippos Apolinario Costa et al. BMJ Case Rep. .
No abstract available

Keywords: brain stem / cerebellum; immunological products and vaccines; lung cancer (oncology); neuroopthalmology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Oh S-Y, Kim J-S, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol 2019;266:1541–8. 10.1007/s00415-018-9138-7 - DOI - PubMed
    1. Mélé N, Hautefort C, Toledano A, et al. . Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report. J Neurol 2016;263:405–6. 10.1007/s00415-015-8012-0 - DOI - PubMed
    1. Antonia SJ, Villegas A, Daniel D, et al. . Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 2017;377:1919–29. 10.1056/NEJMoa1709937 - DOI - PubMed
    1. Manson G, Maria ATJ, Poizeau F, et al. . Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study. J Immunother Cancer 2019;7:337. 10.1186/s40425-019-0821-8 - DOI - PMC - PubMed
    1. Bataller L, Graus F, Saiz A. Spanish opsoclonus-myoclonus study G. clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001;124:437–43. - PubMed

Publication types